Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Brain Imaging and Neuroimaging Market Size, Share, Growth, Trends, and Industry Analysis: By Imaging Type, By Application, By End User and Region
Brain Imaging and Neuroimaging Market size was valued at US$ 35,476.7 million in 2023 and is expected to grow at a 5.9% CAGR from 2024 to 2030. The rising prevalence of neurological disorder, along with the growing geriatric population who are more prone to develop neurological disorder or neurodegenerative disease like Alzheimer’s, epilepsy, Parkinson’s, dementia, and others is expected to drive the growth of brain imaging & neuroimaging market over the forecasted period. In addition, rising new technological advancements and growing investments in research and development is expected to boost the market growth. Furthermore, rising incidence of brain cancer, and increasing number of road accidents across the globe is expected to further fuel the growth of brain imaging and neuroimaging market over the forecasted period. Moreover, rising disease prevalence and awareness in North America region is expected to provide opportunity key market players over the forecasted period.
For instance, according to Parkinson’s foundation almost one million people was suffering from Parkinson’s Disease in 2020, and each year about 60,000 Americans are diagnosed with Parkinson’s disease.Whereas, on the other side high cost of brain imaging and neuroimaging devices is expected to hinder the market growth over the forecasted period. However, the leading key market companies are focused in developing new advanced technological portable brain scanner which are expected to revolutionize the brain imaging by reducing the cost of treatment making the easily accessible by all. For instance, researchers in EM Vision medical devices have developed a portable brain scanner technology which enables to scan brain from any location. However, the high cost of imaging devices is expected to hinder the market growth over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
5.9%Largest Market
North AmericaFastest Growing Market
Europe
The brain imaging and neuroimaging market is expected to grow over the forecasted period due to the increasing prevalence of neurodegenerative disorders and increasing geriatric population who are more prone to develop neurological disorders. According to research study, about 10 to 20 in every 1000 people are diagnosed with neurological disorders like Parkinson’s, Alzheimer’s, epilepsy each year. In addition, innovation of new technology and development of portable brain monitoring devices is expected to fuel the market growth over the forecasted period. For instance, researchers in EM Vision medical devices have developed a portable brain scanner technology which enables it to scan brain from any location.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 35,476.7 million |
Market CAGR |
5.9% |
By Imaging Type |
|
By Application |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global brain imaging and neuroimaging market size was valued at US$ 35,476.7 million in 2023 and is projected to grow at a CAGR of 5.9% by 2030
Increasing prevalence of neuro degenerative disorders, road accidents, brain tumor are expected to drive the market growth.
The leading players in the global Brain Imaging and Neuroimaging market are Varian medical Systems, General Electric Company, Siemens AG, Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Sanrad medical Systems Pvt. Ltd, Esaote SpA, MinFound Medical Systems Co ltd, NeuroSoft, Medtronic Plc.
North America Brain imaging and neuroimaging market is expected to dominate the market over the forecast years.
1.Executive Summary |
2.Global Brain Imaging and Neuroimaging Market Introduction |
2.1.Global Brain Imaging and Neuroimaging Market - Taxonomy |
2.2.Global Brain Imaging and Neuroimaging Market - Definitions |
2.2.1.Imaging Type |
2.2.2.Application |
2.2.3.End User |
2.2.4.Region |
3.Global Brain Imaging and Neuroimaging Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Brain Imaging and Neuroimaging Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Brain Imaging and Neuroimaging Market By Imaging Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Functional Magnetic Resonance Imaging |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Computed Tomography |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Positron Emission Tomography |
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Electro Encephalography |
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Magneto Encephalography |
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Near Infrared Spectroscopy |
5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Others |
5.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
6.Global Brain Imaging and Neuroimaging Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Parkinson’s Disease |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Traumatic Brain Injury |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Epilepsy, Dementia |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Sleep Disorders |
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Brain Imaging and Neuroimaging Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Ambulatory Surgical Centers |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Clinical & Diagnostic Centers |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Brain Imaging and Neuroimaging Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Brain Imaging and Neuroimaging Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. Imaging Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Functional Magnetic Resonance Imaging |
9.1.2.Computed Tomography |
9.1.3.Positron Emission Tomography |
9.1.4.Electro Encephalography |
9.1.5.Magneto Encephalography |
9.1.6.Near Infrared Spectroscopy |
9.1.7.Others |
9.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Parkinson’s Disease |
9.2.2.Traumatic Brain Injury |
9.2.3.Epilepsy, Dementia |
9.2.4.Sleep Disorders |
9.2.5.Others |
9.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Ambulatory Surgical Centers |
9.3.3.Clinical & Diagnostic Centers |
9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Brain Imaging and Neuroimaging Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Imaging Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Functional Magnetic Resonance Imaging |
10.1.2.Computed Tomography |
10.1.3.Positron Emission Tomography |
10.1.4.Electro Encephalography |
10.1.5.Magneto Encephalography |
10.1.6.Near Infrared Spectroscopy |
10.1.7.Others |
10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Parkinson’s Disease |
10.2.2.Traumatic Brain Injury |
10.2.3.Epilepsy, Dementia |
10.2.4.Sleep Disorders |
10.2.5.Others |
10.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Ambulatory Surgical Centers |
10.3.3.Clinical & Diagnostic Centers |
10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11.Asia Pacific (APAC) Brain Imaging and Neuroimaging Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Imaging Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Functional Magnetic Resonance Imaging |
11.1.2.Computed Tomography |
11.1.3.Positron Emission Tomography |
11.1.4.Electro Encephalography |
11.1.5.Magneto Encephalography |
11.1.6.Near Infrared Spectroscopy |
11.1.7.Others |
11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Parkinson’s Disease |
11.2.2.Traumatic Brain Injury |
11.2.3.Epilepsy, Dementia |
11.2.4.Sleep Disorders |
11.2.5.Others |
11.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Ambulatory Surgical Centers |
11.3.3.Clinical & Diagnostic Centers |
11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Brain Imaging and Neuroimaging Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Imaging Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Functional Magnetic Resonance Imaging |
12.1.2.Computed Tomography |
12.1.3.Positron Emission Tomography |
12.1.4.Electro Encephalography |
12.1.5.Magneto Encephalography |
12.1.6.Near Infrared Spectroscopy |
12.1.7.Others |
12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Parkinson’s Disease |
12.2.2.Traumatic Brain Injury |
12.2.3.Epilepsy, Dementia |
12.2.4.Sleep Disorders |
12.2.5.Others |
12.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Ambulatory Surgical Centers |
12.3.3.Clinical & Diagnostic Centers |
12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Brain Imaging and Neuroimaging Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
13.1. Imaging Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Functional Magnetic Resonance Imaging |
13.1.2.Computed Tomography |
13.1.3.Positron Emission Tomography |
13.1.4.Electro Encephalography |
13.1.5.Magneto Encephalography |
13.1.6.Near Infrared Spectroscopy |
13.1.7.Others |
13.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Parkinson’s Disease |
13.2.2.Traumatic Brain Injury |
13.2.3.Epilepsy, Dementia |
13.2.4.Sleep Disorders |
13.2.5.Others |
13.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Ambulatory Surgical Centers |
13.3.3.Clinical & Diagnostic Centers |
13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Varian medical Systems |
14.2.2.General Electric Company |
14.2.3.Siemens AG |
14.2.4.Philips Healthcare |
14.2.5.Toshiba Medical Systems |
14.2.6.Hitachi Medical Systems |
14.2.7.Sanrad medical Systems Pvt. Ltd |
14.2.8.Esaote SpA |
14.2.9.MinFound Medical Systems Co ltd |
14.2.10.NeuroSoft |
14.2.11.Medtronic Plc |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players